Turning Point Therapeutics tptherapeutics.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Turning Point Therapeutics (TP) is a clinical-stage, structure-based, drug design company for the discovery and development of precision medicines for cancer and other diseases. TP Therapeutics is focused on the design of chemical identities for established oncogene drivers with secondary resistant mutations, newly identified, disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity.

Turning Point Therapeutics (TP) is a clinical-stage, structure-based, drug design company for the discovery and development of precision medicines for cancer and other diseases. TP Therapeutics is focused on the design of chemical identities for esta...Show all

Company (IPO / Went public)

Phone: +1 858 926 5251

Fax:

10628 Science Center Drive
Suite 200
San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Turning Point Therapeutics $144.4M Apr 17, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Turning Point Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 13 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Macrocyclic compounds for treating disease Jan 30, 2020 Aug 18, 2020 Patent
Macrocycle kinase inhibitors Jul 27, 2017 Jun 23, 2020 Patent
Diaryl macrocycles as modulators of protein kinases Nov 29, 2018 Apr 14, 2020 Patent
Chiral diaryl macrocycles as modulators of protein kinases Jun 30, 2016 Jun 11, 2019 Patent
Diaryl macrocycle polymorph Jul 05, 2016 May 21, 2019 Patent
See all 13 patents